Grantham, Mayo, Van Otterloo & Co (GMO)’s Varex Imaging VREX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio VREX Stock Details VREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$119K	Buy	+11,418	New	+$123K	﹤0.01%	655
2023 Q3	–	Sell	-11,183	Closed	-$264K	–	694
2023 Q2	$264K	Buy	+11,183	New	+$233K	﹤0.01%	621
2022 Q3	–	Sell	-65,700	Closed	-$1.41M	–	798
2022 Q2	$1.41M	Sell	65,700 -58,600	-47%	-$1.25M	0.01%	480
2022 Q1	$2.65M	Buy	124,300 +33,300	+37%	+$847K	0.01%	414
2021 Q4	$2.87M	Buy	91,000 +19,500	+27%	+$553K	0.01%	414
2021 Q3	$2.02M	Buy	+71,500	New	+$1.98M	0.01%	453
2020 Q4	–	Sell	-60,600	Closed	-$771K	–	890
2020 Q3	$771K	Sell	60,600 -59,500	-50%	-$814K	0.01%	565
2020 Q2	$1.82M	Buy	120,100 +37,900	+46%	+$765K	0.01%	435
2020 Q1	$1.87M	Sell	82,200 -63,500	-44%	-$1.64M	0.02%	388
2019 Q4	$4.34M	Sell	145,700 -8,300	-5%	-$248K	0.03%	306
2019 Q3	$4.39M	Buy	+154,000	New	+$4.46M	0.03%	317

Other funds holding VREX

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s VREX Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Varex Imaging (VREX) in Q2 2026: 11,418 shares worth $119K. The stake represents ﹤0.01% of the portfolio and ranks #655 among its holdings. This is a return to the name: Grantham, Mayo, Van Otterloo & Co (GMO) previously reported a position in VREX as recently as Q2 2023.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in VREX in Q3 2019 and has held it in 11 quarters since. The position peaked at $4.39M in Q3 2019. 187 funds tracked by Wall St. Rank hold VREX as of Q2 2026.

Grantham, Mayo, Van Otterloo & Co (GMO) held 11,418 shares of Varex Imaging worth $119K as of Q2 2026.
Varex Imaging was a new Grantham, Mayo, Van Otterloo & Co (GMO) position in Q2 2026.
Varex Imaging made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #655 holding.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Varex Imaging in Q3 2019 and has held it in 11 quarters since.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Varex Imaging position peaked at $4.39M in Q3 2019.
187 funds tracked by Wall St. Rank held Varex Imaging as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.